Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial

Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial

The prognostic relevance of circulating tumor cells (CTCs) in breast cancer is well established. However, little is known about the association of CTCs and site of first metastasis. In the SUCCESS A trial, 373 out of 3754 randomized high-risk breast cancer patients developed metastatic disease. CTC...

Full description

Bibliographic Details
Main Authors: Elisabeth K. Trapp, Peter A. Fasching, Tanja Fehm, Andreas Schneeweiss, Volkmar Mueller, Nadia Harbeck, Ralf Lorenz, Claudia Schumacher, Georg Heinrich, Fabienne Schochter, Amelie de Gregorio, Marie Tzschaschel, Brigitte Rack, Wolfgang Janni, Thomas W. P. Friedl
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
liquid biopsy
circulating tumor cells (CTC)
breast cancer
metastasis
Online Access:https://www.mdpi.com/2072-6694/14/16/3949

Similar Items

Similar Items